AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23522095 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1086
Study 21102473 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) treatment for a mean duration of 1 year
Number of subjects: 71
Study 21102473 — intervention group
Group type: COMPARATOR
Intervention: No treatment or vitamin E
Number of subjects: 71
Study 21102473 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) treatment
Number of subjects: 71
Study 19920081 — intervention group
Group type: COMPARATOR
Intervention: Physician intervention (internet-based training, self-monitoring, quarterly feedback reports)
Number of subjects: 574
Study 19920081 — intervention group
Group type: COMPARATOR
Intervention: Patient intervention (20 weekly group sessions followed by 12 monthly telephone counseling contacts focusing on weight loss, DASH dietary pattern, exercise, and reduced sodium intake)
Number of subjects: 574
Study 19920081 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of physician and patient interventions
Number of subjects: 574
Study 17998178 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly cross-linked Durasul polyethylene inserts
Number of subjects: 102
Study 17998178 — intervention group
Group type: COMPARATOR
Intervention: Contemporary Sulene polyethylene inserts
Number of subjects: 102
Study 14757463 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrainguinal bypass grafts
Number of subjects: 30
Study 14757463 — intervention group
Group type: EXPERIMENTAL
Intervention: Above knee anastomoses
Number of subjects: 30
Study 14757463 — intervention group
Group type: EXPERIMENTAL
Intervention: Below knee grafts
Number of subjects: 30
Study 11302475 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 0
Study 11302475 — intervention group
Group type: COMPARATOR
Intervention: Aprotinin
Number of subjects: 0
Study 11302475 — intervention group
Group type: EXPERIMENTAL
Intervention: EACA
Number of subjects: 0
Study 9803706 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session, skill-based sexual risk reduction intervention
Number of subjects: 0
Study 9803706 — intervention group
Group type: COMPARATOR
Intervention: AIDS-education-only condition
Number of subjects: 0
Study 7536028 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly carboplatin and teniposide (CBDCA/VM)
Number of subjects: 61
Study 7536028 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine (PAV-CyMOC)
Number of subjects: 61
Study 2496616 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole
Number of subjects: 20
Study 2496616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 71397 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 14
Study 71397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 31605835 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Working Memory Training (eWMT)
Number of subjects: 40
Study 31605835 — intervention group
Group type: COMPARATOR
Intervention: Control Training (CT)
Number of subjects: 40
Study 31370223 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri V3401 (5 × 10^9 colony-forming units)
Number of subjects: 53
Study 31370223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 28663651 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg/4 ml
Number of subjects: 80
Study 28663651 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 4 ml
Number of subjects: 80
Study 28663651 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 25970229 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol at 0.6 mg/kg with additional doses of 10-20 mg until OAA/S score 2-4
Number of subjects: 34
Study 25970229 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine at a loading dose of 1 μg/kg over 10 minutes followed by 0.5 μg/kg/h infusion until OAA/S score 2-4
Number of subjects: 34
Study 25970229 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 34
Study 25970229 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine
Number of subjects: 34
Study 22915314 — intervention group
Group type: EXPERIMENTAL
Intervention: EEA-relevant context specified (surviving on the savannah/grasslands)
Number of subjects: 0
Study 22915314 — intervention group
Group type: COMPARATOR
Intervention: No context specified (simply trying to stay alive)
Number of subjects: 0
Study 21771185 — intervention group
Group type: EXPERIMENTAL
Intervention: F‐File with NaOCl
Number of subjects: 48
Study 21771185 — intervention group
Group type: COMPARATOR
Intervention: Distilled water
Number of subjects: 48
Study 21771185 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl
Number of subjects: 48
Study 21771185 — intervention group
Group type: COMPARATOR
Intervention: RC‐Prep
Number of subjects: 48
Study 21771185 — intervention group
Group type: COMPARATOR
Intervention: Glyde
Number of subjects: 48
Study 21771185 — intervention group
Group type: COMPARATOR
Intervention: MTAD
Number of subjects: 48
Study 19207368 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic intervention applied once a week for 10 sessions
Number of subjects: 26
Study 19207368 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 26
Study 17279195 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study 17279195 — intervention group
Group type: COMPARATOR
Intervention: Other antiemetics
Number of subjects: 0
Study 14759109 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.8% tranexamic acid mouthwash over 2 days
Number of subjects: 85
Study 14759109 — intervention group
Group type: COMPARATOR
Intervention: 4.8% tranexamic acid mouthwash over 5 days
Number of subjects: 85
Study 10685239 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquaphor ointment applied twice daily for 2 weeks
Number of subjects: 19
Study 10685239 — intervention group
Group type: COMPARATOR
Intervention: Standard skin care (Control)
Number of subjects: 19
Study 8596489 — intervention group
Group type: EXPERIMENTAL
Intervention: Trelan G‐75 (1,200 mOsm/L, 225 mL) equivalent to 75 g glucose
Number of subjects: 0
Study 8596489 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g glucose in 225 mL water (33.3% solution)
Number of subjects: 0
Study 8596489 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl solution or water
Number of subjects: 0
Study 8596489 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g glucose in 150 mL water
Number of subjects: 0
Study 8596489 — intervention group
Group type: EXPERIMENTAL
Intervention: Trelan G‐75
Number of subjects: 0
Study 1755396 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerolin Autohaler
Number of subjects: 51
Study 1755396 — intervention group
Group type: COMPARATOR
Intervention: Rotahaler
Number of subjects: 51
Study 6285622 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose polychemotherapy (cyclophosphamide, 5-FU, MTX, and Velbe)
Number of subjects: 0
Study 6285622 — intervention group
Group type: COMPARATOR
Intervention: No polychemotherapy
Number of subjects: 0
Study 3155939 — intervention group
Group type: EXPERIMENTAL
Intervention: Inversion devices (two for inversion)
Number of subjects: 20
Study 3155939 — intervention group
Group type: COMPARATOR
Intervention: GLR suspension traction
Number of subjects: 20
Study 29797421 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid overdose cases (OD)
Number of subjects: 132
Study 27756289 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity measured by Global Physical Activity Questionnaire (GPAQ) and ActiGraph accelerometer; duration: 7 days of accelerometer wear; assessment at 14-18 weeks and 28-33 weeks gestation.
Number of subjects: 80
Study 27756289 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT) conducted at 24-28 weeks gestation.
Number of subjects: 80
Study 24814051 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with chronic pain
Number of subjects: 653
Study 24814051 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants without chronic pain
Number of subjects: 653
Study 24814051 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 653
Study 22397890 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral left sided rTMS
Number of subjects: 67
Study 22397890 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral rTMS
Number of subjects: 67
Study 22397890 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 67
Study 20457669 — intervention group
Group type: COMPARATOR
Intervention: Single IUI (112 patients)
Number of subjects: 228
Study 20457669 — intervention group
Group type: EXPERIMENTAL
Intervention: Double IUI (114 patients)
Number of subjects: 228
Study 20457669 — intervention group
Group type: COMPARATOR
Intervention: Single IUI in unexplained infertility group (45 patients)
Number of subjects: 228
Study 20457669 — intervention group
Group type: EXPERIMENTAL
Intervention: Double IUI in unexplained infertility group (49 patients)
Number of subjects: 228
Study 20457669 — intervention group
Group type: COMPARATOR
Intervention: Single IUI in mild male factor group (67 patients)
Number of subjects: 228
Study 20457669 — intervention group
Group type: EXPERIMENTAL
Intervention: Double IUI in mild male factor group (65 patients)
Number of subjects: 228
Study 18588560 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg once daily
Number of subjects: 736
Study 18588560 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg once daily
Number of subjects: 736
Study 18588560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 736
Study 15759178 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolene
Number of subjects: 140
Study 15759178 — intervention group
Group type: EXPERIMENTAL
Intervention: VyproII
Number of subjects: 140
Study 14733985 — intervention group
Group type: EXPERIMENTAL
Intervention: Degraded image training intervention
Number of subjects: 0
Study 14733985 — intervention group
Group type: COMPARATOR
Intervention: Training intervention
Number of subjects: 0
Study 10710013 — intervention group
Group type: EXPERIMENTAL
Intervention: IT1MIN (continuous test with workload increments each minute)
Number of subjects: 11
Study 10710013 — intervention group
Group type: EXPERIMENTAL
Intervention: IT3MIN (discontinuous test with 3 min stages)
Number of subjects: 11
Study 10710013 — intervention group
Group type: EXPERIMENTAL
Intervention: IT4MIN (discontinuous test with 4 min stages)
Number of subjects: 11
Study 10710013 — intervention group
Group type: EXPERIMENTAL
Intervention: IT5MIN (discontinuous test with 5 min stages)
Number of subjects: 11
Study 10710013 — intervention group
Group type: COMPARATOR
Intervention: All tests
Number of subjects: 11
Study 10710013 — intervention group
Group type: EXPERIMENTAL
Intervention: IT1MIN
Number of subjects: 11
Study 8943993 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched prenatal intervention program
Number of subjects: 0
Study 8943993 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonparticipants and comparison women)
Number of subjects: 0
Study 1767259 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloxacillin prophylaxis
Number of subjects: 175
Study 1767259 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 175
Study 6963163 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole vaginal cream with oral nystatin
Number of subjects: 292
Study 6963163 — intervention group
Group type: COMPARATOR
Intervention: Other treatment regimens (not specified)
Number of subjects: 292
Study 30519793 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantente REAL (MR) curriculum
Number of subjects: 676
Study 30519793 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 676
Study 29547159 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine (30 mg/kg/day) with oral prednisolone (4 mg/kg/day)
Number of subjects: 62
Study 29547159 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (4 mg/kg/day) alone
Number of subjects: 62
Study 27385408 — intervention group
Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) at 33°C
Number of subjects: 939
Study 27385408 — intervention group
Group type: EXPERIMENTAL
Intervention: Target temperature management (TTM) at 36°C
Number of subjects: 939
Study 27385408 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted for confounders
Number of subjects: 939
Study 25607696 — intervention group
Group type: EXPERIMENTAL
Intervention: Non‐ablative 1927nm fractionated thulium laser (Fraxel Dual 1550/1927 Laser System, energy level of 10mJ, coverage of 40% and 4‐6 passes)
Number of subjects: 40
Study 22985607 — intervention group
Group type: COMPARATOR
Intervention: Phlebotomy (450 mL, every 2 weeks until serum ferritin levels of 20 ng/mL)
Number of subjects: 48
Study 22985607 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose hydroxychloroquine (100 mg orally, twice weekly, until at least 1 month after normal plasma levels of porphyrin)
Number of subjects: 48
Study 19438967 — intervention group
Group type: EXPERIMENTAL
Intervention: DAE + CaP surface (NanoTite)
Number of subjects: 15
Study 19438967 — intervention group
Group type: COMPARATOR
Intervention: DAE surface (Osseotite)
Number of subjects: 15
Study 17922939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) group treatment
Number of subjects: 238
Study 17922939 — intervention group
Group type: COMPARATOR
Intervention: COPD education
Number of subjects: 238
Study 16135835 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 1998
Study 16135835 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 1998
Study 12111513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin, 1g every 8h
Number of subjects: 24
Study 12111513 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefozopran, 0.5 g every 8h
Number of subjects: 24
Study 12111513 — intervention group
Group type: EXPERIMENTAL
Intervention: Flomoxef, 1g every 8h
Number of subjects: 24
Study 10332014 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment (24 sessions of 15 minutes, frequency 0.89 MHz, intensity 2.5 W/cm², pulsed mode 1:4)
Number of subjects: 63
Study 10332014 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound treatment
Number of subjects: 63
Study 10332014 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 63
Study 8762303 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning trials with background stimuli moving at a constant horizontal velocity
Number of subjects: 8
Study 8762303 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning stimuli moving to the left (opposite to the direction of eye movement)
Number of subjects: 8
Study 8762303 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning stimuli moving to the right (same direction as eye movement)
Number of subjects: 8
Study 8762303 — intervention group
Group type: EXPERIMENTAL
Intervention: Test trials with 12 deg/sec rightward smooth pursuit
Number of subjects: 8
Study 8762303 — intervention group
Group type: COMPARATOR
Intervention: Additional controls
Number of subjects: 8
Study 1752118 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (40 mg)
Number of subjects: 12
Study 1752118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg)
Number of subjects: 12
Study 1752118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6351824 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of a thick firm pad and tight bandage
Number of subjects: 12
Study 6351824 — intervention group
Group type: COMPARATOR
Intervention: Other methods (not specified)
Number of subjects: 12
Study 31758475 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased adherence to Mediterranean diet (MedDiet)
Number of subjects: 78
Study 29172236 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture repair alone
Number of subjects: 119
Study 29172236 — intervention group
Group type: COMPARATOR
Intervention: Proximal diversion or anastomotic reconstruction
Number of subjects: 119
Study 30634204 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb (80 mg/kg, twice per day) combined with medicinal activated carbon (1.5 g each time, thrice per day) for 8 weeks
Number of subjects: 126
Study 30634204 — intervention group
Group type: COMPARATOR
Intervention: Medicinal activated carbon (1.5 g each time, thrice per day) for 8 weeks
Number of subjects: 126
Study 30634204 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhubarb combined with medicinal activated carbon
Number of subjects: 126
Study 25233867 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support physical activity intervention
Number of subjects: 0
Study 25233867 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 21841087 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot conditions (maximum temperature of 38°C, minimum temperature of 28°C)
Number of subjects: 12
Study 21841087 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral conditions (TNC)
Number of subjects: 12
Study 20611050 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 67
Study 20611050 — intervention group
Group type: COMPARATOR
Intervention: Supportive Therapy
Number of subjects: 67
Study 17884442 — intervention group
Group type: EXPERIMENTAL
Intervention: 375 mg extract of green and black tea per day for 3 months
Number of subjects: 49
Study 17884442 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg extract of green and black tea per day for 3 months
Number of subjects: 49
Study 17884442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 15386765 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-year disease-free survivors
Number of subjects: 267
Study 15386765 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with recurrence
Number of subjects: 267
Study 15386765 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 267
Study 12053829 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention and treatment strategies for traveller's diarrhoea
Number of subjects: 0
Study 12053829 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigation of patients with persistent symptoms after returning home
Number of subjects: 0
Study 9455509 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical paromomycin/MBCL plus injectable Sb for 7 days
Number of subjects: 150
Study 9455509 — intervention group
Group type: COMPARATOR
Intervention: Topical placebo plus injectable Sb for 7 days
Number of subjects: 150
Study 9455509 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical paromomycin/MBCL plus injectable Sb for 3 days
Number of subjects: 150
Study 9455509 — intervention group
Group type: COMPARATOR
Intervention: Injectable Sb for 20 days
Number of subjects: 150
Study 7658950 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 0 mmol.l‐1 Na+
Number of subjects: 12
Study 7658950 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 8.8 mmol.l‐1 Na+
Number of subjects: 12
Study 7658950 — intervention group
Group type: EXPERIMENTAL
Intervention: Drink with 6% carbohydrates and 18.5 mmol.l‐1 Na+
Number of subjects: 12
Study 7658950 — intervention group
Group type: COMPARATOR
Intervention: Water (neither CHO nor Na+)
Number of subjects: 12
Study 2663739 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 80
Study 2663739 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment
Number of subjects: 80
Study 1100361 — intervention group
Group type: EXPERIMENTAL
Intervention: Loxapine
Number of subjects: 49
Study 1100361 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 49
Study 1100361 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 49
Study 30117625 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predicting 1-year overall survival
Number of subjects: 358
Study 30117625 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predicting half-year disease-free survival
Number of subjects: 358
Study 27458234 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled sodium nitrite (90 mg)
Number of subjects: 26
Study 27458234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 24875671 — intervention group
Group type: EXPERIMENTAL
Intervention: High potassium diet
Number of subjects: 35
Study 24875671 — intervention group
Group type: COMPARATOR
Intervention: Low potassium diet
Number of subjects: 35
Study 21978663 — intervention group
Group type: EXPERIMENTAL
Intervention: Painkillers only
Number of subjects: 15272
Study 21978663 — intervention group
Group type: EXPERIMENTAL
Intervention: Painkillers with other medications
Number of subjects: 15272
Study 21978663 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy or exercise
Number of subjects: 15272
Study 21978663 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral to a specialist
Number of subjects: 15272
Study 21978663 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 15272
Study 20038737 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-coated endotracheal tube (ETT)
Number of subjects: 93
Study 20038737 — intervention group
Group type: COMPARATOR
Intervention: Control group (uncoated ETT)
Number of subjects: 93
Study 18601851 — intervention group
Group type: EXPERIMENTAL
Intervention: Dishen Qufeng Decoction (DSQFD)
Number of subjects: 60
Study 18601851 — intervention group
Group type: COMPARATOR
Intervention: Cetirizine
Number of subjects: 60
Study 16794570 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg amantadine
Number of subjects: 14
Study 16794570 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg amantadine
Number of subjects: 14
Study 16794570 — intervention group
Group type: COMPARATOR
Intervention: Amantadine (50 mg and 100 mg)
Number of subjects: 14
Study 14671167 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol instillation
Number of subjects: 66
Study 14671167 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline instillation
Number of subjects: 66
Study 11211584 — intervention group
Group type: EXPERIMENTAL
Intervention: Amnioinfusion
Number of subjects: 0